title: HIV-infected T cells are migratory vehicles for viral dissemination.
abstract: After host entry through mucosal surfaces, human immunodeficiency virus-1 (HIV-1) disseminates to lymphoid tissues to establish a generalized infection of the immune system. The mechanisms by which this virus spreads among permissive target cells locally during the early stages of transmission and systemically during subsequent dissemination are not known. In vitro studies suggest that the formation of virological synapses during stable contacts between infected and uninfected T cells greatly increases the efficiency of viral transfer. It is unclear, however, whether T-cell contacts are sufficiently stable in vivo to allow for functional synapse formation under the conditions of perpetual cell motility in epithelial and lymphoid tissues. Here, using multiphoton intravital microscopy, we examine the dynamic behaviour of HIV-infected T cells in the lymph nodes of humanized mice. We find that most productively infected T cells migrate robustly, resulting in their even distribution throughout the lymph node cortex. A subset of infected cells formed multinucleated syncytia through HIV envelope-dependent cell fusion. Both uncoordinated motility of syncytia and adhesion to CD4(+) lymph node cells led to the formation of long membrane tethers, increasing cell lengths to up to ten times that of migrating uninfected T cells. Blocking the egress of migratory T cells from the lymph nodes into efferent lymph vessels, and thus interrupting T-cell recirculation, limited HIV dissemination and strongly reduced plasma viraemia. Thus, we have found that HIV-infected T cells are motile, form syncytia and establish tethering interactions that may facilitate cell-to-cell transmission through virological synapses. Migration of T cells in lymph nodes therefore spreads infection locally, whereas their recirculation through tissues is important for efficient systemic viral spread, suggesting new molecular targets to antagonize HIV infection.
authors.affiliation: The Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
authors.forename: Thomas T
authors.initials: TT
authors.lastname: Murooka
authors.forename: Maud
authors.initials: M
authors.lastname: Deruaz
authors.forename: Francesco
authors.initials: F
authors.lastname: Marangoni
authors.forename: Vladimir D
authors.initials: VD
authors.lastname: Vrbanac
authors.forename: Edward
authors.initials: E
authors.lastname: Seung
authors.forename: Ulrich H
authors.initials: UH
authors.lastname: von Andrian
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Tager
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Luster
authors.forename: Thorsten R
authors.initials: TR
authors.lastname: Mempel
mesh_terms: D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000821:virology*; D002465:Cell Movement; D002478:Cells, Cultured; D004195:Disease Models, Animal; D005260:Female; D015726:Giant Cells; D006678:HIV / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology* / Q000635:transmission / Q000821:virology*; D006801:Humans; D008198:Lymph Nodes / Q000821:virology; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D008822:Mice, Transgenic